Gaining Informational Advantage with Proprietary Alt Data – By Julia Valentine, MBA

AI-Amp’d Industry Intel: How medical companies are actively expanding their informational advantage by incorporating alt data into their risk, R&D, investment and other key processes

By Julia Valentine, MBA

Imagine a world where perfect market research information is available to everyone at the same time. In this scenario, the concepts of investment and business competition would be radically changed—not just within the medical and healthcare sectors but far beyond. If perfect information were available to everyone, it would be difficult if not impossible for any one entity to identify an underserved market or underpriced asset. When companies and investors develop the expertise to spot mispricing and other indicators and anomalies, they often start with identifying a way to collect vital data that provides an informational advantage over their competition.

The most obvious way in which main street companies and investment funds gain an informational advantage is through developing a proprietary way to collect data. Alternative data, or data that supplements traditional financial data available through annual financial reports or exchanges, provides a valuable window into market or consumer behavior. Satellite data can track shipments and parking lots. Credit card data can illuminate who’s spending what and where.

Most companies buy data feeds from over 400 alternative data providers. So prolific is this emerging sector, a recent report reveals the global alternative data market size is anticipated to reach $143.31 billion by 2030 driven, in large party, by the escalating number of data providers coupled with ever-evolving procurement and extraction methods. While North America currently dominates the space (67%) and is forecasted to do so through 2030, alt data-driven market research is also burgeoning globally.

However procured and analyzed, one thing is certain: companies slow to use alt data expose themselves to extreme opportunity loss at best and operational peril at worst–as addressed in the topics list bulleted below.

Proprietary ways to acquire and combine alternative data for added insight are essential. While using available sources of alternative data certainly add insight, truly proprietary data can be collected through the use of multi-modal AI. Multimodal AI is a new AI paradigm in which various data types (image, text, speech, numerical data) are combined with multiple intelligence processing algorithms to achieve higher performances.

Companies using multi-modal AI amplify their competitive advantage due to faster data collection and improved ability to programmatically turn long form content (visual, audio, text) into relevant pieces of information resulting in significant time efficiencies and faster decision making. Multimodal AI often outperforms single modal AI in many real-world problems. Proprietary data can be collected from social media, web and other sources that are not available to the competition.

When proprietary data is collected, timely analysis makes a difference. In a rapidly changing world, it’s essential to operate with timely and accurate data. Research & Development departments need to react to the current customer needs. Investment firms react to rapidly changing market conditions. Every market player needs to consider how to utilize alternative data in the best possible way.

Agile companies pivot quickly when they are able to obtain proprietary data and analyze it quickly. Wholesalers and retailers can change their inventory every few weeks because they can analyze their sales data, trends and other data points in a timely way and create the merchandise that answers identified up-to-the-minute consumer behaviors. Gaining insights from alternative data is only valuable when they can be parlayed into market action in a way that is cleverly conceived and masterfully executed.

Editor’s Note: Julia Valentine, MBA,  a solution-focused FinTech Advisor to boards and management teams,  is Managing Partner at AlphaMille—a full-service company providing technology advisory and consulting services worldwide relating to software development and implementation, data analytics and data management, model valuation, and more.   

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

What consumers and health professionals may not realize is the critical importance of utilizing proper temperature monitoring tools, to stay informed about their health, and also to evaluate the severity of illness, helping to determine if medical attention is needed. Learn more.
Caroline Petersen writes, "Forging an emotional connection and bonding with potential customers is critical to converting prospects into lifelong clients, but doing so can be challenging in complex fields like medical devices, where products involve intricate scientific engineering and precise functionality. This is where the power of visual storytelling comes in." Learn more.
For this American Heart Month, Dr. Trotter is equipping Scribes with essential life-saving knowledge, providing CPR training and enabling them to make a meaningful impact during life or death situations. Read on.
Last year was one of the worst years ever for cyber attacks on healthcare organizations. According to John Riggi, national advisor for cybersecurity and risk for the American Hospital Association, the number of people affected by attacks broke records, with US federal data indicating that around 106 million people were impacted by a healthcare data breach, more than double when compared to 2022.
Moby Cutter™ is one of the safest surgical wire cutters on the market today! Their medical design team has over 35 years of experience performing surgical procedures in Hospitals, Emergency Rooms and Urgent Care Systems. It has been cleared for commercialization per FDA guidelines and sold as a prescription only (Rx) medical device. Dr. Stanley shares the advantages of the Moby Cutter.

By using this website you agree to accept Medical Device News Magazine Privacy Policy